Personalis (PSNL) EBITDA (2018 - 2026)
Personalis (PSNL) EBITDA from Jun 30, 2018 to Mar 31, 2026. The TTM Personalis (PSNL) EBITDA is -$93M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Personalis (PSNL) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +64.37% |
| 3 Years TTM | -4.85% |
| 5 Years TTM | +18.82% |
| All Time TTM | +43.24% |
Annual EBITDA change of Personalis (PSNL)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | -$30M | -61.81% |
| 2025 | -$78M | +36.07% |
| 2024 | -$57M | -41.88% |
| 2023 | -$99M | -7.90% |
| 2022 | -$107M | +80.49% |
| 2021 | -$59M | +63.07% |
| 2020 | -$36M | +105.94% |
| 2019 | -$18M | +65.14% |
| 2018 | -$11M | -48.93% |
| 2017 | -$21M | N/A |
Comparison Personalis (PSNL) five years EBITDA CAGR with competitors
Personalis (PSNL) five years EBITDA CAGR is 18.83%.
| Ticker | Name | five years EBITDA CAGR | Upside |
|---|---|---|---|
| PRPH | ProPhase Labs Inc | 73.15% | +288.54% |
| MEDP | Medpace Holdings Inc | 25.16% | +33.64% |
| ISPC | iSpecimen Inc | 25.14% | +33.52% |
| WAT | Waters Corp | 17.45% | -7.29% |
| BNR | Burning Rock Biotech Ltd | 17.26% | -8.32% |
| ICLR | Icon Plc | 12.53% | -33.43% |
| IDXX | Idexx Laboratories Inc | 11.66% | -38.05% |
| CSTL | Castle Biosciences Inc | 10.29% | -45.36% |
| MTD | Mettler-Toledo International Inc | 9.87% | -47.59% |
| MYNZ | Mainz Biomed N.V. | 9.82% | -47.84% |
| IQV | IQVIA Holdings Inc | 9.14% | -51.44% |
| RDNT | Radnet Inc | 8.38% | -55.46% |
| IMDX | Insight Molecular Diagnostics Inc | 7.62% | -59.55% |
| A | Agilent Technologies Inc | 6.59% | -65.00% |
| ILMN | Illumina Inc | 5.98% | -68.22% |
| GH | Guardant Health Inc | 5.67% | -69.88% |
| NTRA | Natera Inc | 3.35% | -82.20% |
| TWST | Twist Bioscience Corp | 2.84% | -84.92% |
| BDSX | Biodesix Inc | 2.43% | -87.07% |
| SHC | Sotera Health Company | 2.32% | -87.67% |
| QGEN | Qiagen NV | 2.21% | -88.29% |